Merck KGaA (0O14.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 05:36PM BST
| Previous close | 156.05 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 120,094 |
| Market cap | 71.628B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | 21.87 |
| EPS (TTM) | 7.08 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | 2.20 (1.48%) |
| Ex-dividend date | 02 May 2023 |
| 1y target est | N/A |
- Investing.com
Merck KGgA shares slide after failure of potential head and neck cancer drug
Investing.com -- Shares in Merck KGaA (ETR:MRCG) slumped by more than 10% on Tuesday after the drugmaker announced that it had discontinued a Phase III study evaluating its treatment for patients with head and neck cancer.
Simply Wall St.Merck KGaA's (ETR:MRK) Stock Has Fared Decently: Is the Market Following Strong Financials?
Most readers would already know that Merck KGaA's (ETR:MRK) stock increased by 4.5% over the past three months. Given...
ZacksHere's What Could Help Merck KGaA (MKGAF) Maintain Its Recent Price Strength
Merck KGaA (MKGAF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.